ERIC Number: EJ1441183
Record Type: Journal
Publication Date: 2024-Mar
Pages: 9
Abstractor: As Provided
ISBN: N/A
ISSN: ISSN-1087-0547
EISSN: EISSN-1557-1246
Available Date: N/A
Medication Treatment for Youth in Substance Use Disorder Residential Treatment
Amy M. Yule; Victoria Mail; Rebecca Butler; Timothy E. Wilens
Journal of Attention Disorders, v28 n5 p791-799 2024
Objective: Residential is a common treatment setting for youth with high-severity substance use disorders (SUD). This study evaluated the prevalence of psychiatric symptoms and medication for youth in residential SUD treatment. Methods: Youth in Massachusetts state licensed and funded SUD residential programs completed questionnaires assessing demographics, primary substance of use, and psychopathology symptoms (Youth Self Report [YSR]/Adult Self Report [ASR]). De-identified medication lists were provided by the programs. Descriptive statistics were used to describe the sample. Results: Among the 47 youth who participated, 51.1% were male, 72.3% white, 83% non-Hispanic, mean age 20.7 years. Opioids were the most common primary substance identified by youth (51.1%), and 75% had at least one clinically elevated subscale on the YSR/ASR. Most youth were prescribed at least one medication (89.4%) with a mean of 2.9 medications. Conclusion: Youth in SUD residential treatment frequently have clinically elevated psychiatric symptoms, and psychotropic medication was commonly prescribed.
Descriptors: Drug Therapy, Youth, Residential Institutions, Symptoms (Individual Disorders), Mental Disorders, Incidence, Narcotics, Drug Abuse, Substance Abuse, Medical Services, Smoking, Antisocial Behavior, Anxiety, Depression (Psychology), Attention
SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: https://sagepub-com.bibliotheek.ehb.be
Publication Type: Journal Articles; Reports - Research
Education Level: N/A
Audience: N/A
Language: English
Sponsor: National Center for Advancing Translational Sciences (NCATS) (DHHS/NIH)
Authoring Institution: N/A
Identifiers - Location: Massachusetts
Grant or Contract Numbers: 1UL1TR001430
Author Affiliations: N/A